Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Leases (2019 - 2025)

China Pharma Holdings filings provide 7 years of Current Leases readings, the most recent being $71628.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 82.15% to $71628.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $71628.0, a 82.15% increase, with the full-year FY2025 number at $71628.0, up 82.15% from a year prior.
  • Current Leases hit $71628.0 in Q4 2025 for China Pharma Holdings, up from $70326.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $86672.0 in Q1 2022 to a low of $19776.0 in Q1 2025.
  • Median Current Leases over the past 5 years was $74850.0 (2023), compared with a mean of $63959.1.
  • Biggest five-year swings in Current Leases: tumbled 76.21% in 2023 and later soared 279.71% in 2024.
  • China Pharma Holdings' Current Leases stood at $85282.0 in 2021, then crashed by 52.57% to $40445.0 in 2022, then soared by 92.18% to $77727.0 in 2023, then crashed by 49.41% to $39323.0 in 2024, then soared by 82.15% to $71628.0 in 2025.
  • The last three reported values for Current Leases were $71628.0 (Q4 2025), $70326.0 (Q3 2025), and $19776.0 (Q1 2025) per Business Quant data.